Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-26

Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topical minocycline FXFM244 for rosacea was terminated; the document does not report results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical Minocycline FXFM244 (minocycline)

Snippet

Sponsor: Vyne Therapeutics Inc. | Conditions: Rosacea | Phase 2 | Status: TERMINATED